It is a non-invasive genetic test for bowel cancer which examines the DNA code for 11 genes known to cause an increased risk of bowel cancer. It is performed on a blood sample and if possible it is more informative to test a relative who has had bowel cancer first.
This report contains market size and forecasts of DNA Bowel Cancer Screening Kits in Global, including the following market information:
Global DNA Bowel Cancer Screening Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global DNA Bowel Cancer Screening Kits market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Sample Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of DNA Bowel Cancer Screening Kits include Singapore Cancer Society, BTNX Inc., Eiken Chemical Co., LTD, One Step, Kaiser Permanente and Quest Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DNA Bowel Cancer Screening Kits companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Bowel Cancer Screening Kits Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global DNA Bowel Cancer Screening Kits Market Segment Percentages, by Type, 2021 (%)
Blood Sample
Fecal Sample
Global DNA Bowel Cancer Screening Kits Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global DNA Bowel Cancer Screening Kits Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home
Global DNA Bowel Cancer Screening Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global DNA Bowel Cancer Screening Kits Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DNA Bowel Cancer Screening Kits revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies DNA Bowel Cancer Screening Kits revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Singapore Cancer Society
BTNX Inc.
Eiken Chemical Co., LTD
One Step
Kaiser Permanente
Quest Diagnostics